Coeptis Therapeutics Holdings- Warrants (31/10/2025) Common Stock

The latest common stock for COEPW is $660 as of March 2026. That compares with $340 in the prior-year period — up 94.7% year over year. Investors often review this figure alongside Coeptis Therapeutics Holdings- Warrants (31/10/2025)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, COEPW's common stock moved from $340 to $660 — a 94.7% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Coeptis Therapeutics Holdings- Warrants (31/10/2025)'s operating scale or balance-sheet position.

A common stock figure of $660 for COEPW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting COEPW's common stock ($660), review year-over-year change from $340, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.